Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Screenetics contract win

18th Nov 2013 07:00

RNS Number : 2240T
Ultrasis PLC
18 November 2013
 

Ultrasis plc

("Ultrasis" or the "Company")

 Ultrasis Group acquisition, Screenetics, scores contract wins

Ultrasis announces that its recently-acquired screening and wellbeing subsidiary, Screenetics UK Limited ("Screenetics"), has won three new contracts with customers spanning the public and private sectors. The value of the contracts is an estimated £2 million per annum. The revenues are partly conditional on performance, but, based on past experience, Screenetics is confident of fulfilling the contract criteria.

Ultrasis acquired Screenetics on the 4th October 2013 as part of its strategy to broaden the range of products and services it provides and to enable it to become a provider of wellbeing, health and social care services.

The contracts relate to the provision of:

· 9,500 flu vaccinations (currently being delivered, one year contract);

· health screenings as part of a salary sacrifice scheme to a large public sector body (commences February 2014 ,three year contract); and

· employee screening to a large UK corporate company (commences spring 2014, initially one year contract).

"This is positive news for both the Screenetics team and for Ultrasis," said John Smith, Ultrasis' Chief Executive. "We are delighted to have secured these significant contracts so soon after the acquisition and believe Screenetics is now well positioned to secure further contract gains. The strength of Screentics in the wellness and screening market is their absolute focus on quality customer service and in delivering the very best experience for the individual using their services".

 Kevin Hollick, Screenetics' Managing Director, said: "We have been strengthened by becoming part of the Ultrasis Group and it is encouraging to see these contracts come to fruition, I am confident that 2014 is going to be a significant year of growth for the Screenetics business. We are planning for the volume of health assessments we provide to quadruple in the next 12 months and these contracts put us well on the way to exceeding our expectations".

He added "2014 also sees the introduction of our first mobile health assessment vehicle which will initially be used to deliver a nationwide road show for a large corporate customer to promote wellbeing in the workplace".

 

 

Ends

 

Editor's notes:

Ultrasis is a healthcare company with core expertise in health, psychology, software development and programme management. We deliver a range of healthcare products to the consumer, the NHS, the corporate sector and other healthcare providers in the UK and Internationally. Ultrasis was the first company to offer computerised products based on Cognitive Behavioural Therapy (CBT) and interactive multimedia, and is still the world leader in this field.

For more information about Ultrasis please visit www.ultrasis.com 

Screenetics is a leading supplier of Health and Wellbeing Services to the Corporate Sector, Private Organisations and the general public. Screenetics has secured a reputation for delivering services that focus on customer care of the highest quality. Based in Milton Keynes and providing a national service it became part of the Ultrasis Group in October 2013.

For more information about Sceenetics please visit www.screenetics.com

 

Enquiries:

For all enquiries relating to Ultrasis please contact

 Ultrasis plc

 

John Smith, Chief Executive

Tel: +44 (0) 20 7535 2050

 

 

 

finnCap Limited

 

Geoff Nash/Simon Hicks

Tel: +44 (0) 20 7220 0500

 

 

 

JBP Public Relations

 

Chris Lawrance

Tel: +44 (0) 11 7907 3400

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTBRBDBUUBBGXR

Related Shares:

Ultrasis Plc
FTSE 100 Latest
Value8,275.66
Change0.00